Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing

(2014) Diana F. Clarke et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Raltegravir Pharmacokinetics During Pregnancy

(2014) D. Heather Watts et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Short Communication: Use of Raltegravir in Late-Presenting HIV-Infected Pregnant Women

(2013) Isabella Nóbrega et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

One-Month Transplacental Pharmacokinetics of Raltegravir in a Premature Newborn after Short-Course Treatment of the HIV-1-Infected Mother

(2013) C. Clavel-Osorio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research

(2013) R DiFrancesco et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Epidemiology of HIV Infection in Women and Children: A Global Perspective

(2013) Avinash K. Shetty   CURRENT HIV RESEARCH

HIV seroconversion in the third trimester of pregnancy: using raltegravir to prevent mother-to-child transmission

(2013) A Hegazi et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review

(2013) Laura De Hoffer et al.   JOURNAL OF CHEMOTHERAPY

Raltegravir in the prevention of mother-to-child transmission of HIV-1

(2012) Aseel Hegazi et al.   AIDS

Rapid Decline in HIV Viral Load When Introducing Raltegravir-Containing Antiretroviral Treatment Late in Pregnancy

(2012) Katarina Westling et al.   AIDS PATIENT CARE AND STDS

Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected Patients

(2012) Matthew L. Rizk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

(2012) Kajal Buckoreelall et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetic and safety of raltegravir in pregnancy

(2012) Leonardo Croci et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

British HIV Association guidelines for the management of HIV infection in pregnant women 2012

(2012) GP Taylor et al.   HIV MEDICINE

Combination Antiretroviral Use and Preterm Birth

(2012) D. H. Watts et al.   JOURNAL OF INFECTIOUS DISEASES

Raltegravir in pregnancy: a case series presentation

(2011) N Taylor et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

(2011) D. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Therapeutics in Pregnancy

(2011) Maisa N. Feghali et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women

(2010) Denise A Mckeown et al.   AIDS

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

(2010) C. Pinnetti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination

(2007) H. Jeong et al.   XENOBIOTICA